Association of Lipoprotein‐Associated Phospholipase <scp>A2</scp> and Lipoprotein(a) With the Risk of Recurrence Stroke in Patients With Acute Ischemic Stroke
This investigation underscores the potential advantage of leveraging the combined impact of Lp-PLA2 in conjunction with Lp(a) as a more precise and cost-effective predictive tool for the risk of recurrence stroke in patients with AIS.
Authors
- Shenyang Zhang (ORCID: https://orcid.org/0000-0001-5968-4134)
- Yanlong Zhou
- Hao Li (ORCID: https://orcid.org/0000-0001-8502-2556)
- Hailiang Li (ORCID: https://orcid.org/0000-0002-8215-6193)
- Yu Feng
- Shiguang Zhu
- Ruiguo Dong
Institutions
- Xuzhou Medical College (CN)
Publication Details
- Journal
- Journal of Clinical Laboratory Analysis
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/jcla.25120
- Citations
- 5
- Primary Topic
- Protease and Inhibitor Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 1.43